Tangui Maurice

25PUBLICATIONS
63CO-AUTHORS
PharmacogenomicsArtificial life and complex adaptive systemsBiomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 29, 2026
σ1 receptor agonists: the new trend or an emerging therapeutic option?

|Jun 24, 2026
Enhanced cognitive protection through the combination of Amylovis-201, an anti-amyloidogenic agent with sigma-1 receptor agonist activity, and environmental enrichment in mice.

|Apr 13, 2026
Rational Design and Evaluation of Rivastigmine-Based Pleiotropic Prodrugs for the Treatment of Alzheimer's Disease.

Valentin Travers-Lesage, Marc Since, Alice Wang

|Mar 07, 2026
Xanthatin-13-(Pyrrolidine-2-Carboxylic Acid), a Sesquiterpene Lactone Isolated From Burdock Leaf, Attenuated Aβ25-35 Toxicity and Memory Deficits in a Pharmacological Mouse Model of Alzheimer's Disease.

Charlyne Barry-Simonnet, Lucie Crouzier, Tristan Moujellil-Legagneur

|Feb 05, 2026
Development of Second-Generation Phenoxyethylpiperidines as Potent Sigma-1 Receptor Agonists with Neuroprotective Potential for Alzheimer's Disease.

Francesco Mastropasqua, Anna Teresa Lisi, Lucie Crouzier

|Jan 27, 2026
A Dual Approach To Combat Alzheimer's Disease through Concomitant hBChE Inhibition and S1R Activation.

Kora Reichau, Lucie Crouzier, Eleonora Poeta

Pageof 5

Frequent Collaborators

7 joint publications

Benjamin Delprat

6 joint publications

Michael Decker

5 joint publications

Elodie M Richard

4 joint publications

Lucie Crouzier